两日五单、43亿美元,中国创新药在“ESMO+季节性”双窗口里加速出货|行业风向标

钛媒体APP
Oct 22

图片由AI生成十月中旬的创新药赛道,正被密集的BD交易与学术会议成果点燃。10月16-17日,仅两天内,国内市场一口气落地至少5单创新药BD,合计首付款超2亿美元,潜在总金额42.66亿美元,涵盖自免、眼科、肿瘤,药物形式聚焦双抗、CAR-T、ADC等前沿领域,转让大多面向欧美市场,涉及罗氏、Kite Pharma等知名跨国企业及大型制药企业。与此同时,刚刚收尾的2025年欧洲肿瘤内科学会(...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10